Background - Endothelin-1 (ET-1) is a potent bronchoconstrictor which
may have a role in the pathogenesis of asthma. The levels of ET-1 in s
aliva, induced sputum, and plasma from asthmatic and nonasthmatic subj
ects were compared. Methods - Sputum induction was performed on 28 ast
hmatic subjects and nine normal volunteers. ET-1 levels were measured
in plasma, saliva, and sputum samples and reversed phase high performa
nce Liquid chromatography (RP-HPLC) was performed on saliva and sputum
samples. Results - ET-1 was present in the following order of concent
ration in both normal and asthmatic subjects: saliva > sputum > plasma
(saliva, median 30.1 and 23.9 pg/ml, respectively; sputum, median 15.
5 and 11.2 pg/ml; plasma, median 3.1 and 3.6 pg/ml). There were no dif
ferences between asthmatic and normal subjects in the levels of ET-1 i
n each fluid. The levels of ET-1 in asthmatic subjects were not influe
nced by whether or not they were taking inhaled steroids. RP-HPLC of s
putum and saliva confirmed the presence of ET-1 in these fluids. Concl
usions - Levels of ET-1 can be measured in saliva and sputum obtained
by sputum induction in asthmatic and healthy subjects and, although no
difference was found in basal levels of ET-1 in sputum, saliva and pl
asma between normal subjects and asthmatics without bronchoconstrictio
n, it is apparent that ET-1 is produced or released locally within the
respiratory tract in concentrations higher than those in plasma.